BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
21 results:

  • 1. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
    Yao Y; Wang Y; Ye L; Lu B; Lu W
    Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The WID-EC test for the detection and risk prediction of endometrial cancer.
    Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
    Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer.
    Cortés-Sarabia K; Alarcón-Romero LDC; Flores-Alfaro E; Illades-Aguiar B; Vences-Velázquez A; Mendoza-Catalán MÁ; Navarro-Tito N; Valdés J; Moreno-Godínez ME; Ortuño-Pineda C
    Biomed J; 2021 Dec; 44(6 Suppl 2):S171-S178. PubMed ID: 35491677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
    Scharl S; Gerken M; Sprötge T; Kronberger K; Scharl A; Ignatov A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
    Acta Oncol; 2021 Jul; 60(7):897-903. PubMed ID: 33905297
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. How to Select Early-Stage Cervical cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study.
    Pedone Anchora L; Turco LC; Bizzarri N; Capozzi VA; Lombisani A; Chiantera V; De Felice F; Gallotta V; Cosentino F; Fagotti A; Ferrandina G; Scambia G
    Ann Surg Oncol; 2020 Jun; 27(6):1947-1955. PubMed ID: 31898100
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
    Raffone A; Travaglino A; Mascolo M; Carbone L; Guida M; Insabato L; Zullo F
    Gynecol Oncol; 2019 Nov; 155(2):374-383. PubMed ID: 31472940
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.
    Yunokawa M; Yoshida H; Watanabe R; Noguchi E; Shimomura A; Shimoi T; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):127-134. PubMed ID: 28540420
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
    Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
    Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings.
    Maneschi F; Ceccacci I; Perugini A; Pane C; Simeone A; Manicone A
    Arch Gynecol Obstet; 2012 Feb; 285(2):521-7. PubMed ID: 21779772
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
    Holm R; de Putte GV; Suo Z; Lie AK; Kristensen GB
    Int J Med Sci; 2008 Jun; 5(3):121-6. PubMed ID: 18566674
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.
    Borgfeldt C; Bendahl PO; Gustavsson B; Långström E; Fernö M; Willén R; Grenman S; Casslén B
    Int J Cancer; 2003 Nov; 107(4):658-65. PubMed ID: 14520707
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [The clinical evaluation of endometrial carcinoma following irradiation for cervical cancer].
    Sheng X; Sun J; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):553-5. PubMed ID: 10806734
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Mixed uterine mesodermal sarcoma in the population of southern Israel in the years 1996-1971--clinical and pathological characteristics].
    Ariad S; Rabinovitz A; Yanai-Inbar I; Piura B
    Harefuah; 1998 Jan; 134(2):93-6, 159. PubMed ID: 9517289
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Radical hysterectomy for cervix uteri cancer. Experience with 217 patients].
    Torres Lobatón A; Matías Salvador M; Hernández Aten D; Román Bassaure E
    Ginecol Obstet Mex; 1991 Jan; 59(1):8-14. PubMed ID: 2066014
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The value of postoperative irradiation in endometrial cancer of pathohistologic stage I].
    Kucera H; Vavra N; Weghaupt K
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):618-24. PubMed ID: 2777049
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.